Global Brain has invested in Metalenz, Inc. (Metalenz), a pioneer in the metasurfaces space and the first company to commercialize meta-optics, through its GB-VIII Growth Fund Investment Limited Partnership (GB-VIII). Metalenz, founded in 2016, is the first company to commercialize meta-optics. With exclusive worldwide license to the portfolio of foundational intellectual property relating to metasurfaces developed in the Capasso Lab at Harvard University, Metalenz has more than 20 patents on innovations that simplify and improve optical devices across multiple markets. The company’s meta-surface technology provides complex, multifunctional optical performance in a single semiconductor layer, relocating large-scale production of optics to semiconductor foundries. Their technology produces incredibly compact, lower cost (simpler) optic modules and superior performance (better & brighter images) for many camera applications including mobile devices, AR/VR and automotive. Global Brain has highly recognized the first mover advantage and the foundational IPs of Metalenz technology and decided to invest in Metalenz. Global Brain will support Metalenz’s business development in Japan.

About Metalenz

Location: Boston, USA
CEO: Rob Devlin, Ph. D.
Founded: October 2016
URL: https://www.metalenz.com/

About GB-VIII

Name: GB-VIII Growth Fund Investment Limited Partnership
General Partner: Global Brain Corporation

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com/

Global Brain has invested in Metalenz, Inc., the first fabless semiconductor optics company, revolutionizing optical sensing